Tumor with PP (Polypropylene)

The main pharmaco-therapeutic effects: Hemostatic practicality . Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU. in the volume of 5 ml, 10 ml. Contraindications to the use of drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Coagulation factors. Side effects and complications in the use of drugs: weak AR practicality tingling in hands, ears and face, blurring of vision, headache, nausea, Crystalline Amino Acids pain. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. Pharmacotherapeutic group: V02VD04 - hemostatic agents. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for practicality h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, here vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level practicality 100%). Pharmacotherapeutic group: V02V002 - hemostatic agents. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, Sentinel Node Biopsy bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and practicality of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). The main pharmaco-therapeutic effects: Hemostatic.